Long-Term Treatment with Erlotinib for EGFR Wild-Type Non-Small Cell Lung Cancer: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|6|1|189-196

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.6, Iss.1, 2013-03, pp. : 189-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of FDG-PET-Induced Treatment Choices on Long-Term Outcome in Non-Small Cell Lung Cancer

By  

Respiration, Vol. 79, Iss. 2, 2009-05 ,pp. : 97-104

Karger

Access to resources Recommend Favorite

Detection of EGFR T790M Mutation in Pericardial Effusion from a Non-Small Cell Lung Cancer Patient with Erlotinib Therapy

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-01 ,pp. : 15-20

Karger

Access to resources Recommend Favorite

Long-Term Survival in a Patient with Non-Small Cell Lung Cancer Presenting as Small Intestinal Obstruction

By  

Oncology Research and Treatment, Vol. 33, Iss. 4, 2010-03 ,pp. : 178-180

Karger

Access to resources Recommend Favorite

Pneumothorax during Pemetrexed Treatment in a Patient with Non-Small Cell Lung Cancer: A Case Report and Literature Review

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-05 ,pp. : 428-432

Karger

Access to resources Recommend Favorite

Erlotinib after Failure of Gefitinib Treatment of More Than 6 Months in Advanced Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 1-2, 2012-01 ,pp. : 8-9

Karger

Access to resources Recommend Favorite